Millendo Therapeutics, Inc.
MLND · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | -$36 | -$45 | -$27 |
| Dep. & Amort. | $0 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $4 | $4 | $1 |
| Change in WC | $0 | $0 | -$2 | $1 |
| Other Non-Cash | $36 | $0 | $0 | $1 |
| Operating Cash Flow | $0 | -$30 | -$41 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$1 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $4 | $2 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | $4 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $29 | $5 | $27 | $39 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25 | $5 | $27 | $78 |
| Financing Cash Flow | $25 | $5 | $27 | $78 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9 | -$25 | -$10 | $56 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $64 | $74 | $18 |
| End Cash | $31 | $39 | $64 | $74 |
| Free Cash Flow | -$0 | -$30 | -$42 | -$24 |